Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.590
+0.250 (7.49%)
At close: Dec 20, 2024, 4:00 PM
3.610
+0.020 (0.56%)
After-hours: Dec 20, 2024, 7:56 PM EST
Q32 Bio Employees
Q32 Bio had 37 employees as of December 31, 2023.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,638,135
Market Cap
43.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Achilles Therapeutics | 215 |
| CASI Pharmaceuticals | 176 |
| Barinthus Biotherapeutics | 130 |
| ImmuCell | 79 |
| Xilio Therapeutics | 73 |
| Passage Bio | 58 |
| Rallybio | 43 |
QTTB News
- 10 days ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 11 days ago - Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program - PRNewsWire
- 6 weeks ago - Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - PRNewsWire
- 2 months ago - Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - PRNewsWire
- 4 months ago - Q32 Bio to Participate in Upcoming September Investor Conferences - PRNewsWire
- 4 months ago - Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 - Seeking Alpha
- 5 months ago - 8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% - Benzinga